Surgery Partners runs a national network of 126 ambulatory surgery centers and surgical hospitals across 31 states, providing a setting for non-urgent procedures like orthopedics and gastroenterology.
The company's revenue comes from its Surgical Facility Services and Ancillary Services segments, which generated USD 3.31B in 2025. Despite a 23.12% gross margin, the business is not yet profitable, with a net loss of USD 0.08B.
Surgery Partners benefits from high barriers to entry in the surgical facility market, given regulatory approvals and capital requirements. However, its moat is eroding as UnitedHealth Group's Optum and other large players aggressively acquire independent surg
None yet
None yet
Director DeLuca Teresa made a significant purchase of Surgery Partners, Inc. stock, increasing holdings by 17%. This follows recent sales, marking a notable shift in insider activity.
Main discussion
Director (DeLuca Teresa) at Surgery Partners, Inc. $SGRY purchased $143.50K (largest purchase ever, out of 4). This increased their listed holdings by 17%. Reversal: they made 2 straight sales before this purchase. Their last purchase was 1832 days ago. https://t.co/evLZg6WhJ3
🚨Insider Trade Alert🚨! Insider DeLuca Teresa has purchased 10,000 shares in $SGRY Surgery Partners, Inc. worth $143,500.00 $SGRY current value: $13.60 Market: NASDAQ full disclosure: https://www.sec.gov/Archives/edgar/data/1685627/000163883326000079/0001638833-26-000079-index.htm
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice
